首页 | 本学科首页   官方微博 | 高级检索  
     

miR-155对乳腺癌细胞增殖、凋亡及耐药蛋白表达的调控作用研究
引用本文:陈淑如,黄宇康,吴楚成,陈迪,方勤,彭伟强. miR-155对乳腺癌细胞增殖、凋亡及耐药蛋白表达的调控作用研究[J]. 临床肿瘤学杂志, 2015, 20(2): 108-111
作者姓名:陈淑如  黄宇康  吴楚成  陈迪  方勤  彭伟强
作者单位:惠州市中心人民医院乳腺外科
摘    要:目的 探讨microRNA-155(miR-155)对乳腺癌MCF-7细胞增殖、凋亡及乳腺癌耐药相关蛋白表达的调控作用。方法 采用实时荧光定量PCR(qRT-PCR)法检测MCF-7细胞和人乳腺正常上皮细胞中miR-155的表达水平。将MCF-7细胞分为4组:对照组、空转染组、抑制(转染miR-155 inhibitor)组和过表达(转染miR-155 mimics)组,采用qRT-PCR检测转染24、48、72及96 h后各组的转染效果,噻唑蓝(MTT)法检测各组转染24、48、72及96 h的增殖能力,采用流式细胞仪PI/Annexin V双染色法检测各组转染24、48 h后的凋亡率,Western blotting法检测各组转染48 h后乳腺癌耐药蛋白(BCRP)、P-糖蛋白(P-gp)及多药耐药相关蛋白1(MRP1)的表达水平。结果 乳腺癌MCF-7细胞中的miR 155水平高于人乳腺正常上皮细胞(P<0.05),且转染miR-155 inhibitor或mimics可呈时间依赖的方式降低或升高MCF-7细胞的miR-155水平(P<0.05)。与对照组相比,抑制组转染后的细胞增殖率及BCRP、P-gp和MRP1的表达水平均降低,凋亡率升高(P<0.05);而过表达组的细胞增殖率及BCRP、P gp和MRP1的表达水平均升高,凋亡率降低(P<0.05)。结论 MCF-7细胞中miR-155呈高表达,下调miR-155表达可抑制其增殖及耐药相关蛋白的表达,同时诱导凋亡。

关 键 词:MicroRNA-155  乳腺癌  细胞增殖  耐药

Regulatory effect of miR-155 on the proliferation,apoptosis and expression of breast cancer resistance protein
CHEN Shuru,HUANG Yukang,WU Chucheng,CHEN Di,FANG Qin,PENG Weiqiang. Regulatory effect of miR-155 on the proliferation,apoptosis and expression of breast cancer resistance protein[J]. Chinese Clinical Oncology, 2015, 20(2): 108-111
Authors:CHEN Shuru  HUANG Yukang  WU Chucheng  CHEN Di  FANG Qin  PENG Weiqiang
Affiliation:Department of Breast Surgery, Huizhou Municipal Central Hospital
Abstract:Objective To explore the regulatory effect of microRNA-155 (miR-155) on the proliferation, apoptosis and expression of breast cancer resistance protein. Methods The real-time quantitative PCR (qRT-PCR) was employed to measure the miR-155 level in MCF-7 cells and human normal breast epithelium cells. The MCF-7 cells were randomly assigned into four groups according to the experiment protocol: control group, blank group, inhibition group (transfection with miR-155 inhibitor) and over-expression group (transfection with miR-155 mimics). The qRT-PCR was used to detect the transfection effect at 24, 48, 72 and 96 h after transfection. Methyl thiazolyl tetrazolium (MTT) assay was used to assess the proliferation ability at 24, 48, 72 and 96 h after transfection. The apoptosis rate was evaluated at 24 and 48 h after transfection by PI/Annexin V double staining with flow cytometry. Western blotting was used to measure the expression levels of breast cancer resistance protein (BRCP), P-glycoprotein (P-gp) and multidrug resistance associated protein 1 (MRP1) protein. ResultsThere was higher level of miR-155 in MCF-7 cells versus human normal breast epithelium cells (P<0.05). Transfection with miR-155 inhibitor or mimics could reduce or increase the level of miR 155 in time dependent manner in MCF-7 cells (P<0.05); In comparison with control group, the rates of proliferation and expression levels of BRCP, P-gp and MRP1 decreased in inhibition group but increased in over expression group (P<0.05). The apoptosis rate increased in inhibition group but decreased in over expression group(P<0.05). Conclusion There is higher level of miR-155 in MCF-7 cells. Down-regulation of miR-155 presents an inhibitory effect on the proliferation and expression of drug resistance related protein along with the induction of apoptosis.
Keywords:MicroRNA-155  Breast cancer  Cell proliferation  Drug resistance
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《临床肿瘤学杂志》浏览原始摘要信息
点击此处可从《临床肿瘤学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号